Objective. Individuals with SLE have a heightened risk of developing atypical cervical smears or cervical cancer. Many studies have investigated the association between SLE and cervical neoplasia risk. However, the risk for SLE associated with cervical neoplasia risk is unclear. The present meta-analysis clarified the risk of cervical neoplasia in patients with SLE.
Introduction
Cervical cancer is the second most commonly occurring cancer in women and accounts for up to 300 000 annual deaths [1] . The list of mentioned causes for cervical cancer in various sources includes early sexual activity, multiple sexual partners, HPV infection, genital warts, sexually transmitted diseases, genital tract abnormalities, age, smoking, passive smoke, poor nutrition, immunodeficiency and malnutrition, among others [2] [3] [4] [5] [6] . Several studies [2, [7] [8] [9] have shown a possible link between SLE and cervical cancer. Along with a high infection rate of HPV in SLE patients, many studies have shown an increased incidence of cervical cancer in SLE patients and other studies have noted a high risk of abnormal Pap tests in women with SLE.
SLE is a multi-organ system, autoimmune disease with numerous immunological and clinical manifestations [10] . It is believed to develop as a result of dysregulation of the immune system, ultimately leading to the clinical features of inflammation such as HPV [11] . In addition to the clinical manifestations of SLE itself, female patients also have to contend with a heightened risk of developing abnormal cervical smears and squamous intra-epithelial lesions (SILs) of the cervix as well as other cancers [12] . Recently research has shown that SLE syndrome represents a permissive effect of immunosuppression on increased host susceptibility to high cancer-risk HPV infections, the causative agents of SIL and cervical cancer [2, 7, 8, 13, 14] . One study showed an increased incidence of cervical cancer in SLE and other studies have noted a high risk of abnormal Pap tests in women with SLE [15] . Meta-analysis is a widely accepted tool for summarizing studies and exploring their relationship [16] . One of the major advantages of meta-analysis is to increase the sample size, which may solve the problem of lack of power. Therefore the current study was designed to evaluate the relationship between SLE and cervical cancer risk through meta-analysis using previous relevant studies.
Methods

Data sources
We searched the Excerpta Medica database (EMBASE), Web of Science, Cochrane database and MedLine (using PubMed as the search engine) to identify suitable studies; no lower date limit was applied. Articles were also identified using the related article's function in PubMed References of articles identified were also searched manually. In addition, our own files were manually searched and authors were contacted. Original articles were obtained, and all reference lists were scanned for further relevant articles. Sincere attempts were made to contact the authors of the included studies to obtain individual patient data for the meta-analysis; however, we could not obtain the individual patient data.
Search strategy and study selection
The first association study of SLE with the risk of cervical cancer was published in 1976 [17] . The search terms were search strategy of '(SLE OR systemic lupus erythematosus OR lupus) AND (cervical neoplasia OR cervical cancer)', or 'SLE, Cervical neoplasia', or 'lupus'. Although no language restrictions were imposed initially, for the full-text review and final analysis our resources only permitted review of English articles. Conference abstracts were excluded because of the limited data presented in them. Manuscripts were selected if they met all the following requirements: the diagnosis of SLE was established using the classification criteria of the ACR [18] ; the study was designed using case-control samples; the distribution of SLE in patients and in controls was available; and the study was published as a full paper, not as a meeting abstract or review. Conference abstracts and letters to journal editors were excluded because of the limited data they contained. The following information was extracted from each study: first author, year of publication, study population and the numbers of patients and controls for the study. Two reviewers (H.L.L. and K.Y.) independently determined study eligibility; differing decisions were resolved by consensus. Publications that may have been based on the same study (e.g. same authors, institutions, period of study) were discussed by H.L., Q.D., K.Y., T.Z., G.L. and G.W., and only the best-quality study was used.
Data extraction and statistical analysis
The final set of English articles was assessed independently by two reviewers (H.L.L. and K.Y.). The reviewers were blinded to publication details and differences between them were resolved by consensus. Data retrieved from the reports included author, publication year, participant characteristic, test method, P-value, as well as a study quality score. The conditions for the inclusion of papers were as follows: case-control study of relationship between SLE and risk of cervical neoplasia; case and control diagnosis exactly; every study had integrated data. The conditions for the exclusion of papers are as follows: no case and control study; without integrated data; repeated studies. The heterogeneity of the studies was assessed on the basis of the Breslow-Day test using a significance level of 0.05. All analyses were carried out using Review Manager 4.2 software with forest plot, whole odds ratio (OR) and 95% CI (Cochrane Review Manager software, the Cochrane Collaboration).
Results
Eligible studies
A total of 318 potentially relevant studies were identified based on the above search terms, and all of the retrieved studies were independently evaluated. After screening the abstracts, 232 studies were excluded because of irrelevance (n = 199), including other diseases (n = 33). Further assessment for more detailed information identified 75 ineligible studies because of duplication (n = 18), case report (n = 22), not English (n = 8) or Review article (n = 27). Four [12, 15, 19, 20] publications were excluded for not case-control studies. Finally, seven case-control studies were scrutinized in full text as appropriate (Fig. 1) . In total, our study included 445 cases and 3379 controls studying the relationship between SLE and cervical neoplasia (Table 1) .
Association between SLE and cervical neoplasia
The Breslow-Day test for heterogeneity was significant ( 2 = 21.32, P = 0.002) for different study groups in the seven replication studies, and the common OR calculated was 4.17 (95% CI 3.03, 5.74; P < 0.00001; Fig. 2 ). Our results showed the great difference between case and control groups with an increased risk of cervical neoplasia with SLE.
Bias evaluation
Funnel plots are a visual tool for investigating publication and other bias in meta-analysis [25] . Objective publication bias can lead to overestimation in meta-analysis [26] . Funnel plots need five points for analysis of publication and other bias [27] . For identifying publication bias, a funnel plot was used, which is a scatter plot of ORs of enrolled studies on the x-axis against the standard error of log OR of each study on the y-axis [28] . If there is no publication bias, ORs of small-scale studies scatter widely at the bottom of the graph, with the spread narrowing among large-scale studies. The funnel plot resembles a symmetrical inverted funnel in the absence of publication bias, whereas publication bias makes the funnel plot asymmetrical. In our study, we included seven studies for the investigation of publication and other bias with funnel plots. From Fig. 3 , we found five points in the funnel plots and two points beyond. Publication and other bias may be the reason, so caution should be used when drawing this conclusion.
Discussion
Cervical cancer is the second most commonly occurring cancer among women and is the primary cause of cancer-related deaths in developing countries [29] , where about 200 000 women die from the disease. Previous studies have suggested an association between SLE and cervical cancer, but the determinants of the association are unclear [30] [31] [32] . Previous studies have demonstrated an increased prevalence of atypical cervical smears in patients with SLE, ranging from 24 to 36%, compared with a prevalence of 45-15% in controls [8, 12] . In those studies, immunosuppressants [20, 21] , high rate of HPV infection were closed for the development of cervical dysplasia. Although most HPV infections go away on their own without causing any type of abnormality, infection with high-risk HPV types increases the chance that mild abnormalities will develop and progress to more severe abnormalities or cervical cancer. So the American College of Obstetrics and Gynecology (ACOG) Cervical Cancer Screening Guidelines have been revised: for women age 21-29 years, cervical cytology screening is recommended every 2 years. The interval between cervical cytology examinations may be extended to every 3 years for women at least 30 years of age who have had three consecutive negative cervical cytology screening tests and who have no history of cervical intraepithelial neoplasia (CIN) 2 or CIN 3, HIV infection, immunocompromised state or sexually transmitted diseases (STDs). Previous studies [20, 21] showed that women with SIL were more likely to be treated with cyclosporine (CYC)/ prednisolone or CYC/prednisolone/AZA than prednisolone or prednisolone/AZA. Indeed, the OR for increased [23] found no association between SLE and cervical cancer, maybe because of sample size. The latest study [24] provides evidence that, even though not presenting the classic risk factors for cervical cancer, SLE patients, especially those exposed to long-term immunosuppression, have increased chances of presenting more pre-malignant lesions than the general population and they probably need to follow a more stringent cervical cancer prevention programme. This meta-analysis should be interpreted in light of some limitations. First, the exclusion of abstracts and non-English-language studies may have led to publication bias, that is, an inflation of accuracy estimates due to preferential acceptance of papers reporting favourable results [33] . Secondly, sincere attempts were made to contact the authors of the seven studies to obtain individual patient data for the meta-analysis; however, we could not obtain the individual patient data. We could not distinguish the young from the old, even though HPV infection and STDs are known to be the main cause [32] . These facts may act as confounding factors for comparing SLE risk between SLE patients and healthy persons. We also could not evaluate age, STDs, HPV infection and other risk factors for HPV with cervical cancer according to the full paper because of the lack of related data, and the results of this meta-analysis should 
FIG. 2 ORs and 95%
CIs from individual studies testing the association of SLE and cervical neoplasia. The aggregate OR and 95% CI of the risk factor are also given. The weighting factors (weight%) used to calculate the aggregate OR, calculated from the inverse of the variance, are given for each study. The overall ORs for the T-allele were significantly increased in cervical neoplasia and SLE. be interpreted considering different covariates for risk estimation.
In our meta-analysis, there was a large difference between case and control groups with an increased risk of cervical neoplasia with SLE. In contrast to the present study, the consensus in the literature suggests that immunosuppressive treatment probably does contribute to the development of cervical disease in patients with SLE. A meta-analysis is a type of data analysis in which the results of several studies, none of which need find anything of statistical significance, are lumped together and analysed as if they were the results of one large study. The present meta-analysis included five replication studies with an increased risk of cervical neoplasia with SLE. Six out of seven patients, the replication studies with an increased risk of cervical neoplasia with SLE, OR arrange from 0.48 to 25.69. Although there is significant heterogeneity and publication bias for the study, current evidence suggests an increased risk of cervical neoplasia with SLE. The results of these tests should be compared with the results of cervical Pap smears in SLE patients.
Rheumatology key messages
. Individuals with SLE have a heightened risk of developing atypical cervical smears or cervical cancer. . This meta-analysis demonstrates the positive association between SLE and cervical neoplasia risk.
